Validation of Multiplex Serology Detecting Human Herpesviruses 1-5

Brenner, Nicole; Mentzer, Alexander J.; Butt, Julia; Michel, Angelika; Prager, Kristina; Brozy, Johannes; Weissbrich, Benedikt; Aiello, Allison E.; Meier, Helen C. S.; Breuer, Judy; Almond, Rachael; Allen, Naomi; Pawlita, Michael; & Waterboer, Tim. (2018). Validation of Multiplex Serology Detecting Human Herpesviruses 1-5. PLOS ONE, 13(12), e0209379. PMCID: PMC6307738

Brenner, Nicole; Mentzer, Alexander J.; Butt, Julia; Michel, Angelika; Prager, Kristina; Brozy, Johannes; Weissbrich, Benedikt; Aiello, Allison E.; Meier, Helen C. S.; Breuer, Judy; Almond, Rachael; Allen, Naomi; Pawlita, Michael; & Waterboer, Tim. (2018). Validation of Multiplex Serology Detecting Human Herpesviruses 1-5. PLOS ONE, 13(12), e0209379. PMCID: PMC6307738

Octet Stream icon 11744.ris — Octet Stream, 2 kB (2,127 bytes)

Human herpesviruses (HHV) cause a variety of clinically relevant conditions upon primary infection of typically young and immunocompetent hosts. Both primary infection and reactivation after latency can lead to more severe disease, such as encephalitis, congenital defects and cancer. Infections with HHV are also associated with cardiovascular and neurodegenerative disease. However, most of the associations are based on retrospective case-control analyses and well-powered prospective cohort studies are needed for assessing temporality and causality. To enable comprehensive investigations of HHV-related disease etiology in large prospective population-based cohort studies, we developed HHV Multiplex Serology. This methodology represents a low-cost, high-throughput technology that allows simultaneous measurement of specific antibodies against five HHV species: Herpes simplex viruses 1 and 2, Varicella zoster virus, Epstein-Barr virus, and Cytomegalovirus. The newly developed HHV species-specific ('Monoplex') assays were validated against established gold-standard reference assays. The specificity and sensitivity of the HHV species-specific Monoplex Serology assays ranged from 92.3% to 100.0% (median 97.4%) and 91.8% to 98.7% (median 96.6%), respectively. Concordance with reference assays was very high with kappa values ranging from 0.86 to 0.96 (median kappa 0.93). Multiplexing the Monoplex Serology assays resulted in no loss of performance and allows simultaneous detection of antibodies against the 5 HHV species in a high-throughput manner.




JOUR



Brenner, Nicole
Mentzer, Alexander J.
Butt, Julia
Michel, Angelika
Prager, Kristina
Brozy, Johannes
Weissbrich, Benedikt
Aiello, Allison E.
Meier, Helen C. S.
Breuer, Judy
Almond, Rachael
Allen, Naomi
Pawlita, Michael
Waterboer, Tim



2018


PLOS ONE

13

12

e0209379








PMC6307738


11744

Wink Plone Theme by Quintagroup © 2013.

Personal tools
This is themeComment for Wink theme